REVOLUTION Medicines

5 followers

‌

Revolution Medicines is an innovative and dynamic organization of experts working together to discover and develop new medicines for cancer patients.

Industries

Headquarters

Employees

Links

Org chart

Mark A. Goldsmith
President, CEO & Board Chairman

Mark A. Goldsmith

Collapse
Wei Lin
Chief Medical Officer
Peg Horn
Chief Operating Officer
Luan M. Wilfong
Chief Human Resources Officer
Steve Kelsey
President, Research & Development
Adrian Gill
SVP, Medicinal Chemistry
Jan Smith
SVP, Biology
Jack Anders
SVP, Finance & Principal Accounting Officer
Alicia Gardner
SVP, Commercial
Ryan Asay
SVP, Corporate Affairs
Shaoling Li
VP, CMC & Quality
Zhengping Wang
VP, Non-Clinical Development & Clinical Pharmacology
Jeff Cislini
VP & Deputy General Counsel
Pete Wildes
VP, Cancer Biology
Stephen Chan
VP, Clinical Data Management, Statistical Programming, & Clinical Systems
Robert Nichols
VP, Corporate Development
Linnet Zia
VP, Financial Planning & Analysis & Strategy
Tamara Kale
VP, Intellectual Property
Marieke Van Den Haak
VP, Program, Portfolio & Alliance Management
Bojena Bitman
VP, Quantitative Sciences
Sriram Naganathan
VP, Chemistry Manufacturing, & Controls
Zane Rogers
VP, Regulatory Affairs
Hieu le
Vice President, Compliance